From isolation to engagement: Chatbot-delivered narratives as a social surrogate for novice quitters and socially isolated smokers
Patient Education and Counseling · 2026-10 · 151 · 109779
DOI: 10.1016/j.pec.2026.109779 ↗Kurz gefasst
Fachartikel in der Zeitschrift Patient Education and Counseling, 2026-10. Verfasst von Sixiao Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health Sciences, University of Central Florida College of Medicine, Orlando, FL, USA. Electronic address: sixiao.liu@ucf.edu. Hauptthemen laut MEDLINE: Smoking Cessation, Social Support, Smokers, Narration. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: Most smokers desire to quit, yet many rely on unassisted attempts that frequently result in relapses. Facilitating early self-disclosure and support-seeking is a critical first step toward effective cessation. This study examines how message format and a recipient's individual context impact their readiness to engage with various support sources. METHODS: In an experiment, adult smokers (N = 386) were assigned to a control or one of three message conditions: non-narrative, first-person narrative, or chatbot-delivered narrative. The study evaluated intentions to disclose smoking-related experiences and seek support across interpersonal and digital sources, testing moderation by perceived social support and recent quit attempts. RESULTS: Chatbot-delivered narratives significantly increased intentions to disclose experiences to, and seek support from, AI-powered programs. Message engagement with interpersonal and group-based sources was contingent upon perceived social support and recent quit experience. Chatbot delivery increased AI-oriented sharing intention when friend support was low and increased friend sharing when support from significant others was low. For participants without recent quit attempts, narrative-based messages, particularly in chatbot format, were associated with increased intentions to disclose experiences and seek support through group-based services. CONCLUSIONS: It is important to align message strategies with individuals' social ties and stages of change. Narrative messages, particularly in chatbot format, may directly encourage AI-oriented engagement while also benefiting individuals with limited peer support or limited recent quitting experience. PRACTICAL IMPLICATIONS: Health providers can screen perceived social support and recent quit attempts and tailor message delivery accordingly. Integrating narratives into counseling or program intake may encourage disclosure and support-seeking for those who have limited interpersonal and quitting-related resources. Narrative-based chatbots may complement existing services by offering accessible pathways into AI-powered and traditional cessation support.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Population Health Sciences, University of Central Florida College of Medicine, Orlando, FL, USA. Electronic address: sixiao.liu@ucf.edu.
- Department of Public Relations, University of Florida, Gainesville, FL, USA.
- Department of Advertising, University of Florida, Gainesville, FL, USA.
Zitieren
APA
Liu, S., Chu, H., & Sun, Y. (2026). From isolation to engagement: Chatbot-delivered narratives as a social surrogate for novice quitters and socially isolated smokers. Patient Education and Counseling, 151, 109779. https://doi.org/10.1016/j.pec.2026.109779
Vancouver
Liu S, Chu H, Sun Y. From isolation to engagement: Chatbot-delivered narratives as a social surrogate for novice quitters and socially isolated smokers. Patient Education and Counseling. 2026;151:109779. doi:10.1016/j.pec.2026.109779
BibTeX
@article{Liu2026,
author = {Liu, Sixiao and Chu, Haoran and Sun, Yuan},
title = {From isolation to engagement: Chatbot-delivered narratives as a social surrogate for novice quitters and socially isolated smokers},
journal = {Patient Education and Counseling},
year = {2026},
volume = {151},
pages = {109779},
doi = {10.1016/j.pec.2026.109779}
}
EUVIMED